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Background
Nephrocalcinosis (NC) refers to diffuse, fine, renal par-
enchymal calcification, as assessed by radiology or ultra-
sonography. In medullary NC, the calcification tends to
occur in the area of the renal pyramids. It is typically
associated with elevated urinary calcium, phosphate, and
oxalate, or it can occur with alkaline urine. Any disorder
that can lead to hypercalcemia or hypercalciuria may be
implicated. Instead of stone formation, smaller parenchy-
mal calcifications are deposited in the medulla, usually
bilateral and symmetric.
Vitamin D hormones play a central role in calcium
homeostasis. Tight control of the vitamin D system
requires inactivation of its active compound 1,25-dihy-
droxyvitamin D3 (1,25(OH)2D3) through 24-hydroxyla-
tion by means of the enzyme 24-hydroxylase (CYP24A1)
and degradation to calcitroic acid [1].
Recently loss-of-function mutations of vitamin D-24
hydroxylase (gene CYP24A1) have been recognized as a
cause of hypercalcaemia and NC/nephrolithiasis in infants
and adults suffering from Idiopathic Infantile Hypercalcae-
mia (IIH) [2]. Prevalence and natural history of this condi-
tion are still to be defined also in pediatric patients. We
investigated the prevalence of CYP24A1 mutations in a
cohort of pediatric patients with NC referred to our outpa-
tient service from January 2012 to December 2013.
Materials and methods
Nineteen children with NC were investigated, by mea-
suring calcium, phosphate, and vitamin D, and by per-
forming CYP24A1 mutation analysis.
Results
All patients were diagnosed with NC after ultrasono-
graphic assessment at a mean age of 3,5 years and were
analyzed with the diagnostic flowchart proposed by
Ammenti [3] for detecting causes of NC. Sequence
analysis of CYP24A1, which encodes 25-hydroxyvitamin
D 24-hydroxylase, the key enzyme of 1,25-dihydroxyvita-
min D(3) degradation, revealed mutations in three
affected children, two were compound heterozygous for
their specific mutations and one presented only one
mutation in a single allele.
All the affected patients showed hypercalciuria, while
only compound heterozygous patients showed chronic
hypercalcaemia with depressed parathyroid hormone
(PTH).
All the patients had normal renal function, despite high-
grade NC, and were treated with potassium citrate to restore
normal citraturia. Of note all patients suffered of recurrent
urinary tract infections, which disappeared after normaliza-
tion of calciuria due to potassium citrate supplementation.
Conclusion
The results of this study suggest a close relationship
between CYP24A1 mutations, and onset of NC in pedia-
tric patients. However further studies are needed to deter-
mine the prevalence of CYP24A1 mutation in NC
patients, to define natural history and to develop novel
therapeutic approaches.
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